{"id":5361,"date":"2026-09-01T11:00:00","date_gmt":"2026-09-01T11:00:00","guid":{"rendered":"https:\/\/medivox.ai\/?p=5361"},"modified":"2026-08-31T21:08:39","modified_gmt":"2026-08-31T21:08:39","slug":"revised-cancer-patient-pathways-september-1-2026","status":"publish","type":"post","link":"https:\/\/medivox.ai\/en\/reviderte-pakkeforlop-kreft-1-september-2026\/","title":{"rendered":"Revised cancer care pathways from September 1st \u2013 what does it mean for your referral?"},"content":{"rendered":"

All 26 standardized care pathways have been reviewed again, and the changes in pathway timeframes take effect today. For you as the referring physician, one question matters most: what does the note say?<\/em><\/p>\n

\n

Starting today, September 1, 2026<\/strong>, applies to new pathway times in the standardized cancer patient pathways. The Norwegian Directorate of Health has revised all 26 pathways according to a common template, but with individual professional assessments for each pathway \u2013 and the changes in pathway times have been made on a professional basis. At the same time, all diagnostic guides for general practitioners have been updated.<\/p>\n

For the vast majority of those working clinically, this does not dramatically change everyday life. However, it is a good time to look at a link that often determines whether a care pathway gets off to the right start: the information that accompanies the referral.<\/p>\n

What the revision actually entails<\/h2>\n

The purpose of standardized cancer pathways is for cancer patients to experience a well-organized, comprehensive, and predictable trajectory, without unnecessary non-medical delays in investigation, diagnostics, treatment, and rehabilitation. There are 26 organ-specific standardized pathways, a diagnostic pathway for patients with nonspecific symptoms, as well as the \u00abStandardized care pathway home for cancer patients,\u00bb which encompasses everyone who receives a cancer diagnosis.<\/p>\n

In the revision, the Norwegian Directorate of Health has reviewed the content together with the professional communities that update the national action programs for cancer, with the goal that the pathways be clinically updated, more accessible, and clearer for users. The texts have been tightened, and the pathway timeframes have been adjusted where there is a clinical basis for doing so.<\/p>\n

For the general practitioner, the diagnostic guidelines are the most practically relevant: they describe which symptoms and findings indicate a referral to a standardized cancer pathway, and which examinations should be carried out first. It is worth reviewing the guideline for the types of cancer you see most often \u2013 they have all been updated.<\/p>\n

Where the process most often stumbles: the information that didn't follow along<\/h2>\n

A standardized patient pathway does not start by itself. It starts with a referral that is clear enough for the recipient to understand that this is to enter a pathway, and that contains what the hospital needs to assess the degree of urgency correctly right away. The activities in the pathway are then coded with administrative pathway codes according to the reporting guide available at the Norwegian Institute of Public Health<\/a>, so that one can monitor whether the objectives are being met.<\/p>\n

This means that a care pathway is in practice measured by two things simultaneously: the clinical work, and the documentation that makes the work visible. When a referral must be returned for supplementary information, or when it is unclear what was actually done before the referral, time is lost \u2013 time that counts toward the pathway time, but is not due to medical conditions.<\/p>\n

This is not a new phenomenon, and it is not anyone's fault alone. We have previously written about how documentation affects the interaction between the general practitioner and the specialist<\/a>the information is almost always there, but it is scattered, compressed, or written at a time when the details were already starting to fade.<\/p>\n

And there is a time crunch at both ends. The general practitioner who suspects cancer typically has fifteen minutes for a consultation that is both medically and emotionally heavy\u2014and must then write a note and a referral that must hold up professionally. The cancer nurse and the pathway coordinator in specialized healthcare must keep track of a pathway with many contact points, where the patient remembers very little of what was said at a given time.<\/p>\n

The Medivox fits in<\/h2>\n

Medivox is built for that exact gap between the conversation and the written record. You dictate while the consultation is fresh, and receive a structured draft of the clinical note that you edit and approve. From the note, you can also get a draft for a referral<\/a> built on what is already documented \u2013 so that symptom onset, findings, and completed examinations are included, instead of having to be rewritten from memory.<\/p>\n

You build your own templates. It makes sense here: a template for \u00absuspicion of cancer \u2013 work-up\u00bb looks different from a template for a regular check-up, and the templates are adapted to the way you and your practice actually work.<\/p>\n

Two things are worth clarifying. First, Medivox does not handle coding or pathway registration\u2014the administrative pathway codes are entered in the electronic health record and pathway systems as before. Second, Medivox does not make medical assessments. The tool documents the healthcare you have provided; you own the medical record and make the final assessment. Directly identifiable information is pseudonymized before the data is processed further, and all data processing takes place in Norwegian data centers.<\/p>\n

One perspective: predictability is built from small things<\/h2>\n

The standardized pathways were introduced to give patients one of the hardest things to provide in a cancer evaluation: predictability. The revision taking effect today is another step in that direction\u2014professionally updated pathways, clearer texts, adjusted deadlines.<\/p>\n

But that part of the predictability that the patient actually experiences in their own body is built from many small things. That the referral was complete the first time. That the note from the previous contact was legible to the next person. That no one had to ask about the same thing twice. When writing takes up less space<\/a>, there will be both more time for the conversation \u2013 and a better basis for the person taking over.<\/p>\n

Have you reviewed the diagnostic guide for the types of cancer you refer most often?<\/p>\n

Frequently Asked Questions<\/h2>\n

When do the new pathway times in cancer patient pathways apply?<\/strong>
\nThe changes to the pathway times take effect from September 1, 2026, after the Norwegian Directorate of Health has revised all 26 standardized care pathways.<\/p>\n

Are the diagnostic guidelines for general practitioners also changed?<\/strong>
\nYes. All the diagnostic guidelines have been revised. They describe which symptoms and findings indicate referral to a standardized cancer pathway, and which examinations should be performed first.<\/p>\n

Where can I find the rules for sequence coding?<\/strong>
\nThe reporting guide for cancer patient pathways \u2013 formerly known as the coding guide \u2013 is hosted by the Norwegian Institute of Public Health.<\/p>\n

Can speech-to-text help the general practitioner with referrals to standardized pathways?<\/strong>
\nYes, indirect: you receive a structured clinical note from the consultation, and you can build a draft referral based on that. You always perform quality assurance and approve it yourself.<\/p>\n

Is Medivox considering whether the patient should enter a standardized care pathway?<\/strong>
\nNo. Medivox does not have clinical decision support. The tool documents the consultation; the assessment is yours.<\/p>\n

\n

Use Medivox for free<\/strong> \u2013 Get started completely free<\/a><\/p>\n

\n

Do you regularly refer to standardized care pathways and want more of the basis ready directly in the note? Contact us<\/a> \u2013 then we will show you how Medivox fits into a busy consultation day.<\/em><\/p>\n

\n

Sources:<\/strong><\/p>\n